Status:
COMPLETED
An Follow-Up Study of Liver Cirrhosis
Lead Sponsor:
Rohto Pharmaceutical Co., Ltd.
Conditions:
Decompensated Liver Cirrhosis
Eligibility:
All Genders
20+ years
Brief Summary
This is a follow-up study to assess safety and preliminary clinical activity of ADR-001 in patients with liver cirrhosis (Child-Pugh score; Grade B) caused by Hepatitis C or Nonalcoholic Steatohepatit...
Eligibility Criteria
Inclusion
- Liver cirrhosis patients enrolled in ADR-001-01 study and completed the last observation of the study
- Voluntary signed informed consent
Exclusion
- Patients evaluated by investigators as inappropriate
Key Trial Info
Start Date :
March 7 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 12 2023
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT03472742
Start Date
March 7 2018
End Date
October 12 2023
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Niigata University Medical & Dental Hospital
Niigata, Japan, 951-8510